Skip to content
TrialScanner

NCT00683722

PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Phase 2CompletedMESOLead

Registry record

Lead sponsor
Mesoblast, Inc.
Conditions
Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Chronic Bronchitis
Primary completion
Mar 9, 2009Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00683722 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00683722: PROCHYMAL™ (Human Adult Stem... | TrialScanner